stockrow
Friday 6 November 2026
Export SENS’s income statement to Excel — free account
Senseonics Holdings, Inc.
SENS Healthcare Medical Devices
Senseonics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.3 million, up 56.9% from fiscal 2024.
- Revenue
- +117.8%
- EPS
- −75.0%
- Free cash flow
- −223.2%
- Total debt
- +58.4%
Quarter to June 2026, against a year earlier
8.21
0.22
+2.75%
Follow SENS
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | 0 | 6 | 19 | 21 | 5 | 14 | 16 | 22 | 22 | 35 | 49 | +67.9% | 64 | 100 | 138 | +57.4% | |
| Gross margin, % | (98.80) | (53.11) | (43.07) | (91.30) | (350.90) | (5.93) | 16.63 | 13.81 | 2.37 | 44.71 | 54.87 | +143.5 pt | ||||||
| EBT | (44) | (59) | (94) | (116) | (175) | (302) | 142 | (60) | (79) | (69) | (109) | +5.2% | ||||||
| EBT margin, % | (13,231.93) | (927.37) | (496.86) | (542.46) | (3,539.46) | (2,211.88) | 867.16 | (269.73) | (349.84) | (196.03) | (225.34) | +13,035.9 pt | ||||||
| Net income | (44) | (59) | (94) | (116) | (175) | (302) | 142 | (60) | (79) | (69) | (109) | +5.2% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 0.07 | 1.10 | 2.40 | 2.26 | 0.43 | 0.65 | 0.70 | 0.79 | 0.71 | 0.84 | 0.84 | +31.0% | |||||
| Earnings | (9.80) | (10.20) | (12.00) | (12.20) | (15.40) | (14.40) | 6.00 | (2.20) | (2.40) | (1.66) | (2.23) | (17.9%) | ||||||
| Cash flow | (8.52) | (9.61) | (11.53) | (14.42) | (5.92) | (2.66) | (2.83) | (2.47) | (1.92) | (1.42) | (1.66) | (18.1%) | ||||||
| Capex | (0.11) | (0.06) | (0.13) | (0.11) | (0.02) | (0.01) | (0.01) | (0.01) | (0.07) | (0.03) | (0.02) | (14.3%) | ||||||
| Free cash flow | (8.63) | (9.67) | (11.66) | (14.53) | (5.93) | (2.67) | (2.85) | (2.48) | (1.99) | (1.44) | (1.67) | (18.0%) | ||||||
| Book value | (1.09) | 1.25 | 9.05 | (0.92) | (12.64) | (8.79) | (0.11) | 1.26 | (0.53) | 1.46 | 1.56 | n/m | ||||||
| Shares, m | 4 | 6 | 8 | 9 | 11 | 21 | 23 | 28 | 31 | 42 | 48 | +28.2% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.3 | |||||
| P/S | 733.84 | 49.13 | 21.56 | 8.12 | 40.16 | 82.46 | 29.41 | 14.21 | 15.53 | 6.53 | 9.52 | 100.1 | ||||||
| P/B | 0.00 | 43.09 | 5.72 | 0.00 | 0.00 | 0.00 | 0.00 | 8.89 | 0.00 | 3.77 | 5.12 | 6.1 | ||||||
| EV/Sales | 718.30 | 45.68 | 17.92 | 9.04 | 48.69 | 77.54 | 25.78 | 12.41 | 14.99 | 5.66 | 8.30 | 97.6 | ||||||
| EV/FCF | (6.19) | (5.19) | (3.69) | (1.40) | (3.56) | (18.84) | (6.34) | (3.94) | (5.37) | (3.31) | (4.16) | (5.8) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | (38) | (56) | (91) | (136) | (67) | (56) | (66) | (70) | (60) | (59) | (96) | +5.0% | |||||
| Capex | 0 | 0 | (1) | (1) | 0 | 0 | 0 | 0 | (2) | (1) | (1) | +9.9% | ||||||
| Free cash flow | (38) | (56) | (92) | (137) | (68) | (56) | (67) | (71) | (63) | (60) | (97) | +5.1% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | 10 | 22 | 129 | 1 | 14 | 126 | 130 | 113 | 53 | 93 | 142 | +28.4% | |||||
| Net debt | (1) | (12) | (69) | 20 | 42 | (67) | (88) | (68) | (40) | (59) | (87) | +53.1% | ||||||
| Shareholders’ equity | (5) | 7 | 71 | (9) | (144) | (186) | (3) | 36 | (17) | 61 | 90 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | (317.25) | (173.28) | (91.27) | (78.93) | (207.64) | (257.59) | 75.47 | (38.24) | (65.88) | (60.97) | (66.88) | +256.3 pt | |||||
| ROIC | 0.00 | 0.00 | (2,238.70) | (742.40) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (1,867.54) | (2,152.05) | (1,867.5) pt | ||||||
| ROE | 602.85 | (4,945.69) | (239.33) | (369.10) | 229.38 | 183.53 | (151.10) | (363.59) | (817.17) | (310.68) | (118.24) | (913.5) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | 58 | 94 | 192 | 191 | 82 | 89 | 121 | 132 | 117 | 130 | — | +9.4% | |||||
| Revenue/emp, $m | 0.01 | 0.07 | 0.10 | 0.11 | 0.06 | 0.15 | 0.14 | 0.17 | 0.19 | 0.27 | — | +53.5% | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026
Senseonics Holdings, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences, Inc. | $537.7M | — (loss-making) | — (loss-making) | +25.20% (above 0%: growing) | n/m | +72.21% (above 0%: growing) | 85.94% | (24.59%) | Compare |
| DCTH Delcath Systems, Inc. | $502.8M | 1,455× | — (loss-making) | +20.60% (above 0%: growing) | −12.50% (below 0%: shrinking) | −24.45% (below 0%: shrinking) | 89.75% | 8.22% | Compare |
| NPCE NeuroPace, Inc. | $435.6M | — (loss-making) | — (loss-making) | −2.95% (below 0%: shrinking) | n/m | −78.70% (below 0%: shrinking) | 82.83% | (22.53%) | Compare |
| CERS Cerus Corporation | $430.2M | — (loss-making) | — (loss-making) | +6.28% (above 0%: growing) | n/m | +2,471.28% (above 0%: growing) | 57.12% | 0.60% | Compare |
| BWAY Brainsway Ltd. Sponsored ADR | $427.1M | 21.2× | — (loss-making) | +35.43% (above 0%: growing) | +40.00% (above 0%: growing) | −51.68% (below 0%: shrinking) | 74.62% | 13.98% | Compare |
| SI Shoulder Innovations, Inc. | $424.1M | — (loss-making) | — (loss-making) | +37.73% (above 0%: growing) | n/m | +38.63% (above 0%: growing) | 78.47% | (46.92%) | Compare |
| SENS Senseonics Holdings, Inc. | $422.5M | — (loss-making) | — (loss-making) | +117.82% (above 0%: growing) | n/m | −223.24% (below 0%: shrinking) | 59.10% | (248.48%) | |
| MASS 908 Devices Inc. | $419.5M | — (loss-making) | — (loss-making) | +23.31% (above 0%: growing) | n/m | +150.95% (above 0%: growing) | 51.90% | (79.69%) | Compare |
| SSII SS Innovations International, Inc. | $380.9M | — (loss-making) | — (loss-making) | +39.39% (above 0%: growing) | n/m | −16.62% (below 0%: shrinking) | 50.94% | (16.29%) | Compare |
| Median of peers | $428.6M | — | — | +24.26% | — | +11.01% | 76.55% | (19.41%) |
Pay and ownership Proxy statement filed 6 April 2026
Chief executive’s pay
| Year | Total pay | Actually paid | $100 invested |
|---|---|---|---|
| 2025 | 3.35m | 1.75m | 26.80 |
| 2024 | 3.32m | 3.08m | 19.60 |
| 2023 | 3.59m | 1.99m | 21.35 |
Ownership
Directors and executive officers, together
4.70%
PHC Holdings Corporation
10.40%
Entities affiliated with Robert J. Smith
7.50%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards
at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s
shares at the start of the earliest year shown was worth at each year’s end.
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement